Eclipse MedCorp Introduces Folliceuticals MD - A New Hair Health System

DALLAS, Feb. 27, 2019 /PRNewswire/ -- Eclipse, a leading medical manufacturing company, announced today the introduction of the Folliceuticals MD, a home-use system comprising an oral hair supplement and topical foam. Available only through physicians, Folliceuticals MD targets hair health from the inside out, while complementing in-office hair procedures.

"We see hair procedures as the biggest growth market in the dermatology and aesthetics space," stated Tom O'Brien, CEO of Eclipse. "Combination therapy is well established as the ideal approach for hair loss patients. Folliceuticals MD will help physicians maximize successful outcomes, get patients invested in the process and create a better profit center for the practice."

Folliceuticals MD is the evolution of home hair therapy as it addresses multiple factors related to hair loss while encouraging overall patient health. Developed by board-certified dermatologists and hair loss experts, the proprietary formula for Folliceuticals MD makes it the first hair supplement of its kind to target the microbiome while also serving as a daily vitamin.

Dr. Sanjay Batra, President of Regenerative Medicine at Eclipse worked with expert physicians to develop Folliceuticals MD, and added, "We are very proud of the science behind our proprietary formulations, and we plan to continue clinical evaluation and studies with our network of research physicians."

Androgenetic alopecia is the most common form of hair loss in men and women.  The root cause of this form of hair loss is dihydrotestosterone (DHT), which shrinks hair follicles until they stop producing hair. Folliceuticals MD was specifically designed with a proprietary formulation to address this type of hair loss. Using a topical and oral formulation for men and women, this system represents a best-in-class combination approach to treating hair loss without drugs.

Eclipse will be launching Folliceuticals MD at the 2019 American Academy of Dermatology Annual Meeting in Washington DC, February 28-March 3. Visit Eclipse booth #925 on Sunday at Noon to hear Dr. Jeffrey Rapaport's presentation on incorporating Folliceuticals MD into your dermatology practice.

To request more information about Folliceuticals MD call Eclipse at 800-759-6876 or email [email protected] to schedule a meeting with your representative.

About Eclipse
For more than 25 years, Eclipse has been a leader in the aesthetics industry, helping thousands of medical practices in the United States and around the globe launch new procedures. Eclipse PRP, Micropen and eVIVE have combined to successfully treat over one million patients worldwide. Based in Dallas, TX, our mission is to bring high-efficacy, affordable products to physicians that exceed patient expectations. To learn more about our industry-leading products and how you can Eclipse the competition, visit www.EclipseMed.com.

CONTACT: Matt Longman, [email protected]

SOURCE Eclipse